.png?width=500&height=162&name=Generis%20Logo%20(2).png "Generis Logo (2)")
Recent Posts
-1.png)
Many biopharmaceutical manufacturers are Implementing single-use containment and transfer of media and buffer materials...
.png)
Protein-based therapeutics, specifically monoclonal antibodies (mAbs), have become the focus of pharmaceutical R&D over...
This Q&A eBook with OQSIE will delve into:
Dan Simon, President & CEO of Heliae Tech. Holdings Inc. discusses the last 5 years of the company and creating a...
World Courier is transporting Zika diagnostic test kits to and from South America.
This article first appeared in BioPharm International, October 1, Caroline Hroncich
Organizations entering into an ERP project begin their journey by making a business case for ERP. The effort involves...
Bill Remy is Chairman and Chief Executive Officer at TBM Consulting and a member of the Board of Directors. He has...
Single use powder containment practices are still in their infancy but keeping your product from cross contamination...
Previously many of these technologies were emerging on their own, but not considered collectively. With a recent push...